Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Protons × Lymphoid × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9 Genitourinary 8 Thoracic 7 CNS 6 Gastrointestinal 5 Sarcoma 3 Head & Neck 3 Gynecologic 2 Tumor-Agnostic 1 Lymphoid 1 Endocrine 1 Dermatologic 1

Conditions

Hodgkin Disease 1

Interventions

Cyclophosphamide 739 Rituximab 722 Etoposide 318 Vincristine 310 fludarabine 290 Doxorubicin 284 Cytarabine 283 fludarabine phosphate 255 Methotrexate 251 Dexamethasone 230 Prednisone 227 Lenalidomide 208 Filgrastim 192 Melphalan 164 Radiotherapy 149 Peripheral Blood Stem Cell Transplantation 146 Whole-Body Irradiation 143 Busulfan 138 Bendamustine Hydrochloride 136 venetoclax 135 Mycophenolic Acid 132 ibrutinib 126 Granulocyte Colony-Stimulating Factor 120 Bortezomib 110 Tacrolimus 108 obinutuzumab 103 Gemcitabine 96 Cyclosporine 93 Antilymphocyte Serum 84 Carmustine 81

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02070393 2015-02-04

Breast Sparing

Indiana University

Phase EARLY_PHASE1 Terminated

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡